BSE Live
Mar 30, 16:01Prev. Close
8.01
Open Price
8.09
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Gennex Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 0.62 | 0.69 | 0.31 | 0.33 | 0.32 | |
| Diluted EPS (Rs.) | 0.61 | 0.63 | 0.31 | 0.33 | 0.32 | |
| Cash EPS (Rs.) | 0.65 | 0.55 | 0.29 | 0.37 | 0.39 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 8.12 | 7.51 | 4.39 | 3.48 | 3.15 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 8.12 | 7.51 | 4.39 | 3.48 | 3.15 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 4.16 | 2.94 | 3.61 | 4.84 | 4.72 | |
| PBDIT/Share (Rs.) | 0.86 | 0.74 | 0.44 | 0.53 | 0.56 | |
| PBIT/Share (Rs.) | 0.83 | 0.70 | 0.40 | 0.47 | 0.49 | |
| PBT/Share (Rs.) | 0.75 | 0.65 | 0.33 | 0.40 | 0.40 | |
| Net Profit/Share (Rs.) | 0.62 | 0.52 | 0.25 | 0.31 | 0.32 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 20.68 | 25.03 | 12.26 | 11.04 | 11.83 | |
| PBIT Margin (%) | 19.87 | 23.81 | 11.12 | 9.75 | 10.35 | |
| PBT Margin (%) | 18.03 | 22.08 | 9.23 | 8.32 | 8.48 | |
| Net Profit Margin (%) | 14.84 | 17.66 | 7.00 | 6.40 | 6.76 | |
| Return on Networth / Equity (%) | 7.59 | 6.90 | 5.76 | 8.91 | 10.12 | |
| Return on Capital Employed (%) | 9.93 | 9.22 | 9.01 | 13.57 | 15.42 | |
| Return on Assets (%) | 6.42 | 5.74 | 4.73 | 5.75 | 6.83 | |
| Total Debt/Equity (X) | 0.01 | 0.00 | 0.01 | 0.23 | 0.18 | |
| Asset Turnover Ratio (%) | 0.45 | 0.44 | 0.79 | 0.96 | 100.95 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 6.42 | 5.45 | 4.53 | 1.95 | 1.98 | |
| Quick Ratio (X) | 5.58 | 4.96 | 3.59 | 1.63 | 1.71 | |
| Inventory Turnover Ratio (X) | 4.65 | 2.63 | 4.13 | 6.27 | 11.89 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 219.75 | 299.25 | 87.62 | 97.07 | 55.76 | |
| EV/Net Operating Revenue (X) | 2.32 | 4.48 | 1.35 | 1.59 | 0.93 | |
| EV/EBITDA (X) | 11.23 | 17.90 | 10.97 | 14.36 | 7.90 | |
| MarketCap/Net Operating Revenue (X) | 2.90 | 5.38 | 1.55 | 1.56 | 0.83 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 1.48 | 2.10 | 1.28 | 2.17 | 1.24 | |
| Price/Net Operating Revenue | 2.90 | 5.38 | 1.55 | 1.56 | 0.83 | |
| Earnings Yield | 0.05 | 0.03 | 0.05 | 0.04 | 0.08 |
26.11.2025
Gennex Labs Consolidated September 2025 Net Sales at Rs 37.24 crore, up 18.05% Y-o-Y
24.11.2025
Gennex Labs Standalone September 2025 Net Sales at Rs 29.33 crore, up 18.8% Y-o-Y
11.06.2025
Gennex Labs Standalone March 2025 Net Sales at Rs 23.28 crore, up 9.14% Y-o-Y
03.06.2025
Gennex Labs Consolidated March 2025 Net Sales at Rs 40.33 crore, up 20.36% Y-o-Y
26.11.2025
Gennex Labs Consolidated September 2025 Net Sales at Rs 37.24 crore, up 18.05% Y-o-Y
24.11.2025
Gennex Labs Standalone September 2025 Net Sales at Rs 29.33 crore, up 18.8% Y-o-Y
11.06.2025
Gennex Labs Standalone March 2025 Net Sales at Rs 23.28 crore, up 9.14% Y-o-Y
03.06.2025
Gennex Labs Consolidated March 2025 Net Sales at Rs 40.33 crore, up 20.36% Y-o-Y
31.03.2026
30.03.2026
Wockhardt novel antibiotic Zaynich gets thumbs-up from CDSCO expert panel
30.03.2026
29.03.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth